Tag: US pharma

AstraZeneca and Ironwood’s IBS-C Drug Approved in China

Ironwood Pharmaceuticals’ irritable bowel syndrome treatment Linzess has gained approval in China, opening up a market of up to 14m adults with the condition. The good news coincides with big chang...

Generic for Alzheimer’s and Parkinson’s Approved by FDA

The U.S. Food and Drug Administration (FDA) approved Bridgewater, NJ-based Amneal Pharmaceuticals’ generic version of Novartis’ Exelon Patch (Rivastigmine Transdermal System) for dementia related to A...

GE Healthcare and VUMC to Develop New DIagnostic Tools for Cancer Treatment

New diagnostic tools will be developed by GE Healthcare and Vanderbilt University Medical Centre (VUMC) to help make cancer immunotherapies safer and more accurate. As part of a five-year partnersh...

AbbVie and Tizona to Develop Antibody for Cancer Treatment

AbbVie, a research-based global biopharmaceutical company, and Tizona Therapeutics, Inc., a privately held immunotherapy company, announced on Jan. 3, 2019 that they have entered into a global, strate...

FDA Granted Priority Review Non-Opioid for Postoperative Pain

Heron Therapeutics, Inc., a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient...

First FDA Approved ANDA for OHPC Injections in MDV

Slayback Pharma LLC announced today that the U.S. Food and Drug Administration granted approval of its abbreviated new drug application ("ANDA") for Hydroxyprogesterone Caproate Injection, USP 1,250 m...

FDA Approved Rare Blood Disease Drug

The US Food and Drug Administration (FDA) has approved Ultomiris (ravulizumab) injection for use in the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH). PNH is a rare and...

Vedanta Raised $27m to Investigate Microbiome-Derived Therapies

US-based Vedanta Biosciences has raised $27 million in a Series C financing to investigate microbiome-derived therapies for several indications, including cancer and food allergy. Investors include...

BD Granted by FDA to Detect Viral Gastroenteritis Pathogens

Medtech manufacturer Becton, Dickinson and Company said the FDA granted 510(k) clearance to a molecular diagnostic test it developed to detect and differentiate pathogens that cause viral gastroenteri...

Big Pharma Companies to Raise Drug Prices in January

Novartis AG and Bayer AG are among nearly 30 drugmakers that have taken steps to raise the U.S. prices of their medicines in January, ending a self-declared halt to increases made by a pharma industry...

Prescribing of Naloxone is Recommended by US HHS

The U.S. Department of Health and Human Services (HHS) on Wednesday recommended prescribing or co-prescribing the opioid overdose reversal drug, naloxone, to high-risk patients. The agency’s recomm...